201 related articles for article (PubMed ID: 8306326)
1. Analysis of the p53 gene and its expression in human glioblastoma cells.
Van Meir EG; Kikuchi T; Tada M; Li H; Diserens AC; Wojcik BE; Huang HJ; Friedmann T; de Tribolet N; Cavenee WK
Cancer Res; 1994 Feb; 54(3):649-52. PubMed ID: 8306326
[TBL] [Abstract][Full Text] [Related]
2. Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1.
Albertoni M; Shaw PH; Nozaki M; Godard S; Tenan M; Hamou MF; Fairlie DW; Breit SN; Paralkar VM; de Tribolet N; Van Meir EG; Hegi ME
Oncogene; 2002 Jun; 21(27):4212-9. PubMed ID: 12082608
[TBL] [Abstract][Full Text] [Related]
3. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
[TBL] [Abstract][Full Text] [Related]
4. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of rat glioblastoma multiforme to cisplatin in vivo following restoration of wild-type p53 function.
Dorigo O; Turla ST; Lebedeva S; Gjerset RA
J Neurosurg; 1998 Mar; 88(3):535-40. PubMed ID: 9488309
[TBL] [Abstract][Full Text] [Related]
6. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
[TBL] [Abstract][Full Text] [Related]
7. Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage.
Aloni-Grinstein R; Zan-Bar I; Alboum I; Goldfinger N; Rotter V
Oncogene; 1993 Dec; 8(12):3297-305. PubMed ID: 8247532
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.
Saxena A; Clark WC; Robertson JT; Ikejiri B; Oldfield EH; Ali IU
Cancer Res; 1992 Dec; 52(23):6716-21. PubMed ID: 1358438
[TBL] [Abstract][Full Text] [Related]
9. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.
Matozaki T; Sakamoto C; Suzuki T; Matsuda K; Uchida T; Nakano O; Wada K; Nishisaki H; Konda Y; Nagao M
Cancer Res; 1992 Aug; 52(16):4335-41. PubMed ID: 1322785
[TBL] [Abstract][Full Text] [Related]
10. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
Tada M; Iggo RD; Waridel F; Nozaki M; Matsumoto R; Sawamura Y; Shinohe Y; Ikeda J; Abe H
Mol Carcinog; 1997 Mar; 18(3):171-6. PubMed ID: 9115587
[TBL] [Abstract][Full Text] [Related]
11. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region.
Nakamura H; Yoshida M; Tsuiki H; Ito K; Ueno M; Nakao M; Oka K; Tada M; Kochi M; Kuratsu J; Ushio Y; Saya H
Oncogene; 1998 Feb; 16(8):1009-19. PubMed ID: 9519875
[TBL] [Abstract][Full Text] [Related]
12. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
Wang H; Lai B; Li J
Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human glioblastoma cell growth by WAF1/Cip1 can be attenuated by mutant p53.
Jung JM; Li H; Kobayashi T; Kyritsis AP; Langford LA; Bruner JM; Levin VA; Zhang W
Cell Growth Differ; 1995 Aug; 6(8):909-13. PubMed ID: 8547219
[TBL] [Abstract][Full Text] [Related]
14. Effect of radiation on cytokine and cytokine receptor messenger-RNA profiles in p53 wild and mutated human glioblastoma cell lines.
Yee D; Hao C; Cheung HC; Chen HT; Dabbagh L; Hanson J; Coupland R; Petruk KC; Fulton D; Roa WH
Clin Invest Med; 2001 Apr; 24(2):76-82. PubMed ID: 11368149
[TBL] [Abstract][Full Text] [Related]
15. 3-Methylcholanthrene inactivates the p53 gene in Syrian hamster embryo fibroblasts by inducing a specific intronic point mutation.
Albor A; Flessate DM; Soussi T; Notario V
Cancer Res; 1994 Aug; 54(16):4502-7. PubMed ID: 8044802
[TBL] [Abstract][Full Text] [Related]
16. Genetic alterations associated with glioma progression.
Kleihues P; Lübbe J; Watanabe K; von Ammon K; Ohgaki H
Verh Dtsch Ges Pathol; 1994; 78():43-7. PubMed ID: 7534015
[TBL] [Abstract][Full Text] [Related]
17. Single cell monitoring of growth arrest and morphological changes induced by transfer of wild-type p53 alleles to glioblastoma cells.
Van Meir EG; Roemer K; Diserens AC; Kikuchi T; Rempel SA; Haas M; Huang HJ; Friedmann T; de Tribolet N; Cavenee WK
Proc Natl Acad Sci U S A; 1995 Feb; 92(4):1008-12. PubMed ID: 7862624
[TBL] [Abstract][Full Text] [Related]
18. Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy.
Asai A; Miyagi Y; Sugiyama A; Gamanuma M; Hong SH; Takamoto S; Nomura K; Matsutani M; Takakura K; Kuchino Y
J Neurooncol; 1994; 19(3):259-68. PubMed ID: 7807177
[TBL] [Abstract][Full Text] [Related]
19. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
Davis P; Bazar K; Huper G; Lozano G; Marks J; Iglehart JD
Oncogene; 1996 Sep; 13(6):1315-22. PubMed ID: 8808706
[TBL] [Abstract][Full Text] [Related]
20. Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions.
Negrini M; Sabbioni S; Haldar S; Possati L; Castagnoli A; Corallini A; Barbanti-Brodano G; Croce CM
Cancer Res; 1994 Apr; 54(7):1818-24. PubMed ID: 8137297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]